Average arterial input function for quantitative dynamic contrast enhanced magnetic resonance imaging of neck nodal metastases

BMC Medical Physics

Volumn 9, Issue 1, 2009, Pages

  Shukla Dave, Amita ^a   Lee, Nancy ^a   Stambuk, Hilda ^a   Wang, Ya ^a   Huang, Wei ^a   Thaler, Howard T ^a   Patel, Snehal G ^a   Shah, Jatin P ^a   Koutcher, Jason A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 65949095212     PISSN: None     EISSN: 17566649     Source Type: Journal    
DOI: 10.1186/1756-6649-9-4     Document Type: Article

References (28)

1. Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast-enhanced MR imaging. JP Dyke DM Panicek JH Healey PA Meyers AG Huvos LH Schwartz HT Thaler PS Tofts R Gorlick JA Koutcher D Ballon, Radiology 2003 228 271 278 10.1148/radiol.2281011651 12832588 (Pubitemid 36736103) (Pubitemid 36736103)
2. Pathophysiologic basis of contrast enhancement in breast tumors. MV Knopp E Weiss HP Sinn J Mattern H Junkermann J Radeleff A Magener G Brix S Delorme I Zuna G van Kaick, J Magn Reson Imaging 1999 10 260 266 10.1002/(SICI)1522- 2586(199909)10:3<260::AID-JMRI6>3.0.CO;2-7 10508285 (Pubitemid 29463108) (Pubitemid 29463108)
3. Dynamic contrast-enhanced MR imaging. GV Shah NJ Fischbein D Gandhi SK Mukherji, Top Magn Reson Imaging 2004 15 71 77 10.1097/01.ftd.0000136399.78067. dd 15269609 (Pubitemid 38987405) (Pubitemid 38987405)
4. Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors. M Rijpkema JH Kaanders FB Joosten AJ van der Kogel A Heerschap, J Magn Reson Imaging 2001 14 457 463 10.1002/jmri.1207 11599071 (Pubitemid 32906564) (Pubitemid 32906564)
5. Transcytolemmal water exchange in pharmacokinetic analysis of dynamic contrast-enhanced MRI data in squamous cell carcinoma of the head and neck. S Kim H Quon LA Loevner MA Rosen L Dougherty AM Kilger JD Glickson H Poptani, J Magn Reson Imaging 2007 26 1607 1617 10.1002/jmri.21207 17968962 (Pubitemid 350301150) (Pubitemid 350301150)
6. Quantitative dynamic contrast-enhanced MRI for the assessment of mandibular invasion by squamous cell carcinoma. EM Van Cann M Rijpkema A Heerschap A van der Bilt R Koole PJ Stoelinga, Oral Oncol 2008 44 12 1147 1154 10.1016/j.oraloncology.2008.02.009 18485797
7. Expanding the use of magnetic resonance in the assessment of tumor response to therapy: workshop report. J Evelhoch M Garwood D Vigneron M Knopp D Sullivan A Menkens L Clarke G Liu, Cancer Res 2005 65 7041 7044 10.1158/0008-5472.CAN-05-0674 16103049 (Pubitemid 41161229) (Pubitemid 41161229)
8. Investigation and optimization of parameter accuracy in dynamic contrast-enhanced MRI. HL Cheng, J Magn Reson Imaging 2008 28 736 743 10.1002/jmri.21489 18777534
9. Application of dynamic contrast-enhanced MRI to differentiate malignant lymphoma from squamous cell carcinoma in the head and neck. J Asaumi Y Yanagi H Konouchi M Hisatomi H Matsuzaki K Kishi, Oral Oncol 2004 40 579 584 10.1016/j.oraloncology.2003.12.002 15063385 (Pubitemid 38452677) (Pubitemid 38452677)
10. Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer. PJ Hoskin MI Saunders K Goodchild ME Powell NJ Taylor H Baddeley, Br J Radiol 1999 72 1093 1098 10700827
11. Evaluation of tumor proliferation using dynamic contrast enhanced-MRI of oral cavity and oropharyngeal squamous cell carcinoma. H Konouchi J Asaumi Y Yanagi H Shigehara M Hisatomi H Matsuzaki K Kishi, Oral Oncol 2003 39 290 295 10.1016/S1368-8375(02)00119-7 12618202 (Pubitemid 36255696) (Pubitemid 36255696)
12. Challenges in dynamic contrast-enhanced MRI imaging of cervical lymph nodes to detect metastatic disease. SM Noworolski NJ Fischbein MJ Kaplan Y Lu SJ Nelson L Carvajal RG Henry, J Magn Reson Imaging 2003 17 455 462 10.1002/jmri.10280 12655585 (Pubitemid 36396948) (Pubitemid 36396948)
13. Enhancement effects of test injection with a small amount of MR contrast medium in the oral and maxillofacial region. Y Yanagi J Asaumi H Konouchi M Hisatomi H Matsuzaki J Murakami Y Maki T Unetsubo K Kishi, Eur J Radiol 2006 59 367 370 10.1016/j.ejrad.2006.03.017 16621397 (Pubitemid 44301743) (Pubitemid 44301743)
14. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. GJ Parker C Roberts A Macdonald GA Buonaccorsi S Cheung DL Buckley A Jackson Y Watson K Davies GC Jayson, Magn Reson Med 2006 56 993 1000 10.1002/mrm.21066 17036301
15. Feasibility of using limited population based arterial input function for pharmacokinetic modeling of osteosarcoma dynamic contrast enhanced MRI data. Y Wang W Huang DM Panicek LH Schwartz JA Koutcher, Magn Reson Med 2008 59 1183 1189 10.1002/mrm.21432 18429032
16. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. PS Tofts, J Magn Reson Imaging 1997 7 91 101 10.1002/jmri.1880070113 9039598 (Pubitemid 28365643) (Pubitemid 28365643)
17. Applications to T1, T2, and chemical-shift imaging. A Haase MRI Snapshot FLASH, Magn Reson Med 1990 13 77 89 10.1002/mrm.1910130109 2319937
18. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics. GJ Parker J Suckling SF Tanner AR Padhani PB Revell JE Husband MO Leach, J Magn Reson Imaging 1997 7 564 574 10.1002/jmri.1880070318 9170043 (Pubitemid 28360876) (Pubitemid 28360876)
19. Evidence for shutter-speed variation in CR bolus-tracking studies of human pathology. TE Yankeelov WD Rooney W Huang JP Dyke X Li A Tudorica JH Lee JA Koutcher CS Springer Jr, NMR Biomed 2005 18 173 185 10.1002/nbm.938 15578708 (Pubitemid 40716124) (Pubitemid 40716124)
20. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. HJ Weinmann M Laniado W Mutzel, Physiol Chem Phys Med NMR 1984 16 167 172 6505043
21. A unified magnetic resonance imaging pharmacokinetic theory: intravascular and extracellular contrast reagents. X Li WD Rooney CS Springer Jr, Magn Reson Med 2005 54 1351 1359 10.1002/mrm.20684 16247739 (Pubitemid 41740764) (Pubitemid 41740764)
22. Statistical methods for assessing agreement between two methods of clinical measurements. JM Bland Altman, Lancet 1986 1 307 310 2868172 (Pubitemid 16134762) (Pubitemid 16134762)
23. Estimation of kinetic parameters without input functions: analysis of three methods for multichannel blind identification. DY Riabkov EV Di Bella, IEEE Trans Biomed Eng 2002 49 1318 1327 10.1109/TBME.2002.804588 12450362 (Pubitemid 35304170) (Pubitemid 35304170)
24. Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. TE Yankeelov JJ Luci M Lepage R Li L Debusk PC Lin RR Price JC Gore, Magn Reson Imaging 2005 23 519 529 10.1016/j.mri.2005.02.013 15919597 (Pubitemid 40779238) (Pubitemid 40779238)
25. Reference tissue quantification of DCE-MRI data without a contrast agent calibration. S Walker-Samuel MO Leach DJ Collins, Phys Med Biol 2007 52 589 601 10.1088/0031-9155/52/3/004 17228107 (Pubitemid 46646433) (Pubitemid 46646433)
26. Reproducibility of reference tissue quantification of dynamic contrast-enhanced data: comparison with a fixed vascular input function. S Walker-Samuel CC Parker MO Leach DJ Collins, Phys Med Biol 2007 52 75 89 10.1088/0031-9155/52/1/006 17183129 (Pubitemid 46646267) (Pubitemid 46646267)
27. Estimating the arterial input function using two reference tissues in dynamic contrast-enhanced MRI studies: fundamental concepts and simulations. C Yang GS Karczmar M Medved WM Stadler, Magn Reson Med 2004 52 1110 1117 10.1002/mrm.20243 15508148 (Pubitemid 39453285) (Pubitemid 39453285)
28. Comparison of errors associated with single- and multi-bolus injection protocols in low-temporal-resolution dynamic contrast-enhanced tracer kinetic analysis. C Roberts DL Buckley GJ Parker, Magn Reson Med 2006 56 611 619 10.1002/mrm.20971 16858671 (Pubitemid 44338880) (Pubitemid 44338880)